株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ホルモン補充療法(HRT)の世界市場

Hormone Replacement Therapy (HRT)

発行 Global Industry Analysts, Inc. 商品コード 222499
出版日 ページ情報 英文 198 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
ホルモン補充療法(HRT)の世界市場 Hormone Replacement Therapy (HRT)
出版日: 2016年05月01日 ページ情報: 英文 198 Pages
概要

当レポートでは、ホルモン補充療法の世界市場に注目し、直接取材並びに二次情報調査から得られた市場データや動向分析をもとに、2012-2020年の期間にわたる取引価額の実績と予測を地域(米国、カナダ、欧州、アジア太平洋州、中南米、その他)別に提供するほか、過去6年にわたる市場の経緯や主要・精鋭参入企業40社の最新プロフィールをまとめて、概略以下の構成でお届けします。

第1章 イントロダクション、調査方法、製品の定義

  • 調査の信頼性とレポートの限界
  • 免責事項
  • データの解釈とレポート作成のレベル
    • 定量技法および分析法
  • 製品の定義と調査の範囲

第2章 エグゼクティブサマリー

  • 概観
    • ホルモン補充療法(HRT) - 序
    • 地域区分
    • 現況および将来分析
  • 産業概要
    • 更年期障害とホルモン補充療法 - イントロダクション
    • 代表的エストロゲン療法の概要
    • Women's Health Initiative(WHI)調査 - ホルモン補充療法市場に大打撃
    • ニューミレニアムにおけるホルモン補充療法論争の進化
    • 前回調査データの再評価 - ホルモン補充療法需要に復活の望み
    • IMS(International Menopause Society)統一指針がホルモン補充療法の明瞭性を高める道筋に
    • 更年期統計 - 機会指標
    • 更年期症状に存在する民族差
  • 市場の動向と課題
    • 比較的少数の処置希望女性人口によって制約される市場規模
    • 安全性問題:ホルモン補充療法市場への大きな妨げ
    • 法的難局に直面し続けるメーカー
    • 局所エストロゲン - 比較的安全性が高く効果的
    • 刺激的な機会を提供する経皮ホルモン補充療法製品
    • 植物性エストロゲン - 更年期症状への新たな特効薬か
    • 関心を喚起するダイエットと更年期障害の関連性
    • 大豆ほか植物性エストロゲンの影響度 - 現実性チェック
    • 話題性を増す生物学的同一(バイオアイデンティカル)薬剤
    • 生物学的同一ホルモン - 合成ホルモン補充療法に代わる安全な天然物質か
    • ホルモン補充療法の消費者向け直接広告 - 功罪入り混じる評価
  • 競合環境
    • ホルモン補充療法の世界市場を特徴づける熾烈な競争 - 競合企業・製品事例集
  • 療法プロフィール - 代表的な研究事例を検証する
  • 製品概要
    • ホルモンとは
    • 更年期とは
    • 更年期の症状と不満
    • ホルモン補充療法製品
    • ホルモン補充療法を用いる理由
    • ホルモン補充療法の禁忌
    • 歴史的変遷
    • ホルモン療法の利点
    • ホルモン療法をめぐるリスク
    • ホルモン補充療法におけるホルモン療法とその効果
    • 更年期のホルモン補充療法に潜む利点とリスク
    • エストロゲン単体、プロゲステロン単体および併用によるそれぞれの一般的副作用とあまり一般的でない副作用
    • 潜在的問題
    • 心血管疾患
    • 子宮内膜がん
    • 乳がん
    • 肺がん
    • 躁うつ病
    • 卵巣がん
    • 投与の経路
    • 全身療法
    • バイオアイデンティカルホルモン補充療法(BHRT)
    • 歴史背景
    • 証明能力を上回るクレーム数
    • その他の代替療法
    • 処方薬
    • 植物学
    • 心と体の治療
    • 運動とダイエット
  • 製品発売・承認
  • 最近の産業動向
  • 世界の主要企業
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • その他の国々
  • アジア太平洋州
  • 中南米
  • その他の地域

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6453

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 40 companies including many key and niche players such as -

Abbott Laboratories
AbbVie, Inc.
Allergan plc
Bayer Pharma AG
Hisamitsu Pharmaceutical Co., Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definition and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • HRT - A Prelude
  • The Regional Divide
  • Current and Future Analysis

2. INDUSTRY OVERVIEW

  • An Introduction to Menopause and Hormone Replacement Therapy
  • An Overview of Select Estrogen Therapy Approaches
  • WHI Study- A Major Blow to the HRT Market
  • The HRT Controversy Evolution in the New Millennium
  • Reappraisal of Data from Previous Studies - A Hope for Resurgence in HRT Demand
  • IMS Consensus Guidelines Paving Way for More Clarity of HRT
  • Menopause Statistics - An Opportunity Indicator
  • Ethnic Differences Exist in Menopausal Symptoms

3. MARKET TRENDS & ISSUES

  • Market Size Restricted by Lesser Number of Women Opting for Treatment
  • Safety Issues: A Major Deterrent to the HRT Market
  • Manufacturers Continue to Face Legal Challenges
  • Topical Estrogens - More Safe and Effective
  • Transdermal HRT Products Present Exciting Opportunities
  • Phytoestrogens - The New Panacea for Menopausal Symptoms?
  • Diet Link to Menopause Symptoms Raises Interest
  • Impact of Soy and Other Phytoestrogens - A Reality Check
  • The Growing Buzz around Bioidentical Drugs
  • Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?
    • List of Bio-identical Products Used in Conventional HRT
  • Direct-to-Consumer Advertising for HRT - A Mixed Bag

4. COMPETITIVE LANDSCAPE

  • Intense Competition Marks the Global HRT Market
    • Table 1: Global Sales of Select HRT Products (In US$ Million) (includes corresponding Graph/Chart)
  • The Premarin Saga
  • Health Risks Tarnish Premarin's Image
    • Table 2: Annual Sales of Premarin Family: 2002-2013 (includes corresponding Graph/Chart)
  • Pfizer Seeks Refuge in Line Extensions
  • Better Safety Profile for Duavee - A Shot in the Arm for Pfizer
  • Estrace Cream Drives Revenue Gains in Warner Chilcott's HRT Portfolio
    • Table 3: Annual Sales of Estrace Cream: 2010-2013 (includes corresponding Graph/Chart)
    • Table 4: Annual Sales of Warner Chilcott's HRT Portfolio - Estrace Cream, Estrace Tablets, femhrt and Femring - in US$ Million for Years 2010 & 2011 (includes corresponding Graph/Chart)
  • New Drug Buoys Novo Nordisk's HRT Portfolio
  • Estriol: The Next Generation Estrogen Therapy?
  • What Makes Estriol Work?
  • Topical Estriol - More Promising in Safety
  • Estriol - Used More Commonly Outside the US
  • Entry of Generics Threatens Market Growth Prospects
  • Select Hormone Therapies for Post Menopausal Women by Year of Patent Expiry
  • Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions
  • Select Hormone Therapies for Treatment of Postmenopausal Symptoms by Generic Manufacturers
  • Are Non-Hormonal Therapies A Threat to HRT?
  • Earlier Failures Induce Lethargy in Non-Hormonal Therapies
  • Menerba: A Promising Non-Hormone Therapy for Menopausal Hot Flashes

5. THERAPY PROFILE - A REVIEW OF SELECT RECENT STUDIES CONDUCTED

  • Researchers at Yale University Discover Discontinuation HRT May Lead to Premature Deaths
  • Bioidenticals versus Synthetic Hormone Replacement Therapy Agents
  • Studies at University of Sydney Researchers Reveal the Safety of Short-Term Unopposed Estrogens
  • US Researchers Reveal HRT Risks May be Dependent on Weight and Other Factors
  • Studies Prove HRT to Lower Risk of Pancreatic Cancer
  • University of Texas Reveal HRT Linked to Risks of Kidney Stones
  • Researchers at the Sundsvall Hospital Demonstrate Increased Incidence of Cataract Development in Women Undergoing HRT
  • Researchers at University of Southern California Demonstrate Estrogen Replacement Therapies Lower Stress Levels in Older Women
  • Studies at Uppsala University Hospital Demonstrate HRT is Associated with Improved Muscle Functioning in Postmenopausal women
  • Finnish Study Reveals HRT Usage Assist in the Treatment of Hot Flashes in Post Menopausal Women
  • Researchers at Johns Hopkins University Demonstrate Women Undergoing Hormone Therapy Less Prone to Alzheimer's Disease
  • French Study Reveals Hormone Replacement Pills May Affect Gall Bladder
  • Danish Studies Proves HRT Lowers Risk of Heart Attack and Heart Failure

6. PRODUCT OVERVIEW

  • What are Hormones?
  • What is Menopause?
  • Menopause Symptoms and Complaints
  • Introduction to Hormone Replacement Therapy
  • HRT Products
    • Estrogen
    • Progestins
      • Types of HRT
  • Why HRT?
    • Milestones and Downfalls in the Hormone Replacement Therapy (HRT) Market
  • Contraindications of HRT
  • Historical Progression
    • Advantages and Disadvantages of Using HRT
  • Benefits of Hormone Therapy
    • Relief from Vasomotor Symptoms
    • Vaginal Symptoms
    • Improvement in Sexual Functioning
    • Urinary Health
    • Management of Variations in Body Weight/ Mass
    • Ensuring Quality of Life
    • Osteoporosis
    • Diabetes Mellitus (DM)
    • Impact on Overall Mortality
    • Treatment of Premature Menopause
  • Risks Involved in Hormone Therapy
  • Hormone Therapies in HRT and their Effect
  • Potential Benefits and Risks of HRT in Menopausal Symptoms
  • Common and Less Common Side Effects of Using Estrogen-alone, Progesterone-alone or Combination Therapies
  • Potential Issues
  • Cardiovascular Problems
    • Coronary Heart Disease (CHD)
    • Stroke
    • Venous Thromboembolism (VTE)
  • Endometrial Cancer
  • Breast Cancer
    • Estrogen-Progestogen Therapy
    • Estrogen Therapy
  • Lung Cancer
  • Depression and Mood Swings
  • Ovarian Cancer
  • Routes of Administration
  • Systemic Treatment
    • Pills
      • Advantages and Disadvantages of Oral HRT
    • Vaginal Estrogen Ring
    • Transdermal Estrogen Skin Patches
    • Localized Treatment
      • Vaginal Estrogen Tablets
      • Estrogen Creams
      • Intrauterine Progestin System (IUS)
      • Lower Dose Vaginal Estrogen Ring
      • Vaginal Progesterone Gel
    • Implants
      • Advantages and Disadvantages of HRT Implants
  • Bioidentical Hormone Replacement Therapy (BHRT)
  • Historical Background
  • More Claims than Evidence
  • Other Alternatives
  • Prescription Medication
    • Gabapentin
    • Clonidine
    • SNRIs and SSRIs
  • Botanicals
    • Black Cohosh
    • Phytoestrogens (Isoflavones)
    • Other Botanical Products
    • Non-botanical Supplements
  • Mind/Body therapies
  • Exercise and Diet

7. PRODUCT INTRODUCTIONS/APPROVALS

  • Pfizer Receives FDA Approval for DUAVEE(tm) for Treatment of Vasomotor Symptoms
  • Noven Pharmaceuticals Launches Brisdelle(tm) Capsules
  • Lawley Pharmaceuticals Launches Profeme progesterone Bioidentical Hormone Replacement Cream
  • Bayer Receives FDA Approval for Low-Dose ANGELIQ(r) Tablets
  • Noven Pharmaceuticals Receives USFDA Approval for Minivelle(tm)
  • Mylan Pharmaceuticals Introduces Letrozole Tablets
  • Novo Nordisk Unveils Vagifem(r) 10μg
  • Amgen Obtains FDA Approval for Prolia in Treating Postmenopausal Women at Greater Risk of Osteoporosis

8. RECENT INDUSTRY ACTIVITY

  • Actavis Takes Over Warner Chilcott
  • US FDA Rejects SEFELSA(tm) from Depomed for Treatment of Menopause Symptoms
  • US FDA Advisory Committee Rejects Noven Pharmaceuticals' LDMP, a Low-Dose Mesylate Salt of Paroxetine
  • Piramal to Expand its Hormone Product Capacity in the UK
  • BioSante Pharmaceuticals Merges with ANI Pharmaceuticals
  • Biovive Medicine Establishes New Site for BHRT Production in Boulder
  • TherapeuticsMD Commences Phase I Clinical Trial of Estradiol Vagicap(tm)
  • US FDA Accepts TherapeuticsMD's IND for TX12-004HR
  • TherapeuticsMD Files Patent Application for Proprietary New Formulation Technologies
  • Noven Takes over Commercial Rights to Minivelle(tm) from Novogyne Pharmaceuticals
  • Pfizer Halts Development of PRISTIQ(r) for Treatment of Vasomotor Symptoms
  • Teva Completes Takeover of Theramex
  • Pfizer Global Manufacturing to Reconfigure Global Plant Network
  • Watson Enters into Agreement to Acquire US rights of CLI's Bioadhesive Progesterone Gel
  • Solvay Divests Pharmaceutical Business

9. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (US)
  • AbbVie, Inc. (US)
  • Actavis Plc (Ireland)
  • Bayer Pharma AG (Germany)
  • Bayer Pharma's Hormone Replacement Therapy Product Pipeline
  • Hisamitsu Pharmaceutical Co., Inc. (Japan)
  • Noven Pharmaceuticals, Inc. (US)
  • Merck Sharp & Dohme Corp. (UK)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Orion Corporation (Finland)
  • Pfizer, Inc. (US)
  • Rottapharm Madaus (Italy)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • TherapeuticsMD, Inc. (US)
  • Upsher-Smith Laboratories, Inc. (US)

10. GLOBAL MARKET PERSPECTIVE

    • Table 5: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 6: World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 7: World 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • HRT Market in the US - An Overview
      • List of FDA Approved Drugs for Treatment of Menopause Symptoms by Year of Approval
      • List of FDA-Approved Prescription Estrogen- Only Drugs for Preventing Postmenopausal Osteoporosis
      • List of FDA-Approved Prescription Estrogen- Progestin Combination Drugs for Preventing Postmenopausal Osteoporosis
      • List of FDA-Approved Oral Estrogen Therapy Products for Use in Postmenopausal Indications
      • List of FDA-Approved Progestogens
    • The Menopause Opportunity
    • Table 8: US Female Population Percentage Distribution by Age Group: 2013 (includes corresponding Graph/Chart)
    • Impact of the WHI Study
    • Increasing Preference for Topical Vaginal Products
    • Rising Interest in Low-Dose Hormone Therapies to Lead Market Growth
      • Low-Dose Hormone Replacement Therapy Formulations of Estrogens and Estrogen- Progestin Combinations Available in the United States
    • Are Custom Compounded Bioidenticals Products Better?
      • List of FDA-Approved Bioidentical Hormones
      • Bioidenticals Remains a Lethargic Market in the US
      • Regulatory Scenario for BHRT in the US
      • Issues with Approved Bioidenticals
    • Product Launches/Approvals
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 9: The US Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 10: The US Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Canada - The Birth Place of Estrogens
    • Current Market Scenario
    • The Fallout of the WHI Study
    • Table 11: Canadian Female Population Estimates by Age Group: 2013 (includes corresponding Graph/Chart)
      • List of Approved Prescription Estrogen-Only Drugs for Preventing Postmenopausal Osteoporosis in Canada
      • List of Approved Prescription Estrogen- Progestin Combination Drugs for Preventing Postmenopausal Osteoporosis in Canada
      • List of Approved Topical and Transdermal Estrogens Products in Canada
      • List of Approved Vaginal Estrogen Therapy Products in Canada
      • List of Approved Oral Estrogen Therapy Products for Use in Postmenopausal Indications in Canada
  • B. Market Analytics
    • Table 12: Canadian Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 13: Canadian Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Growing Demand for Topical and Transdermal HRT
    • European Medicines Agency Imposes New Restrictions on Linoladiol HN and Linoladiol N Estradiol Creams
  • B. Market Analytics
    • Table 14: European Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 15: European Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 16: European 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • A Peek into the HRT Prescription Practices in France
  • B. Market Analytics
    • Table 17: French Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 18: French Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Bayer Pharma AG - A Major Germany- Based Player
      • Bayer Pharma's Hormone Replacement Therapy Product Pipeline
  • B. Market Analytics
    • Table 19: German Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 20: German Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3c. ITALY

  • A. Market Analysis
    • Current & Future Analysis
    • Rottapharm Madaus - A Major Italy-based Regional Player
  • B. Market Analytics
    • Table 21: Italian Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 22: Italian Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Post Menopausal Symptoms in British Women
    • British Menopause Society and Women's Health Concern Revises Recommendations on HRT
      • List of the Hormone Replacement Therapy Products Available in the UK
      • List of HRT Products Available in the UK by Format
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 23: The UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 24: The UK Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • HRT Prescription Status in Spain
  • B. Market Analytics
    • Table 25: Spanish Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 26: Spanish Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3f. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 27: Rest of European Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 28: Rest of European Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Focus on Select Regional Markets
      • Australia
      • Dwindling Options for Estrogen Patients - A Growing Concern
      • Japan
      • Japan - A Small yet Growing Market for HRT
      • Menopausal Characteristics and Impact of Diet
    • Hisamitsu Pharmaceutical Co., Inc. - A Major Japan-Based HRT Manufacturer
  • B. Market Analytics
    • Table 29: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 30: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

5. LATIN AMERICA

  • Market Analysis
    • Table 31: Latin American Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 32: Latin American Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 33: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Rest of World Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top